Browsing Category

44232 posts
Based on Two-time winner of the Japan Character Awards Grand Prix, "Chiikawa" The first smartphone app "Chiikawa Pocket" Launching in 43 countries and regions worldwide in late March 2025

Based on Two-time winner of the Japan Character Awards Grand Prix, "Chiikawa" The first smartphone app "Chiikawa Pocket" Launching in 43 countries and regions worldwide in late March 2025

TOKYO, Feb. 13, 2025 /PRNewswire/ — Applibot, Inc. (Headquarters: Shibuya, Tokyo; President:…

XDENT LAB Expands the Largest Removable Denture Factory in Vietnam – Forecasting Strong Growth, Pioneering Dental Lab-to-Lab Services for the U.S. Market

HO CHI MINH CITY, Vietnam, Feb. 13, 2025 /PRNewswire/ — XDENT LAB,…
Hyundai Motor Group Celebrates 20 Years of Driving Innovation at the Hyundai California Proving Ground

Hyundai Motor Group Celebrates 20 Years of Driving Innovation at the Hyundai California Proving Ground

Milestone reaffirms Hyundai Motor Group’s commitment to safety, quality, design, and performance…

Restore Vision Announces First Patient Dosed in Phase I/II Clinical Trial of RV-001 for Gene-Agnostic Retinitis Pigmentosa

The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting…

Aker Horizons ASA: Fourth-quarter results 2024

FORNEBU, Norway, Feb. 13, 2025 /PRNewswire/ — Aker Horizons ASA (OSE: AKH), a developer…

Cloud4C Secures Dual AI Specializations on Microsoft Azure, Strengthening AI Capabilities

SINGAPORE, Feb. 13, 2025 /PRNewswire/ — Cloud4C, a global leader in AI-driven…

Hugel achieves record net sales, profit, net income in 2024

– The company reports KRW373.0 billion in net sales, KRW166.3 billion in…
DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development

SEOUL, South Korea, Feb. 13, 2025 /PRNewswire/ — DAAN Biotherapeutics, a leading…